Security key
26817R108
- Security type / class
- Equity / COM
- Total 13F shares
- 18,546
- Total 13F value
- $193,991
- Share change
- +18,546
- SEC-reported price per share
- $10.46
- Number of holders
- 1
- Value change
- +$193,991
- Number of buys
- 1
Report period
Q1 2025
Institutions
1
Top holders
1
DYN full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2025
Dyne Therapeutics, Inc. SEC filings
Dyne Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 26817R108
Recent filing periods:
Ownership snapshot
Top reported holders of DYN - DYNEGY INC NEW DEL - COM (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Forbion Capital Fund IV C...
Disclosed value leader
Atlas Venture Life Scienc...
Comparable rows
15/15
Latest evidence
31 Mar 2025
13D/G
13F
Lead comparable stake: 4.8%
13D/G row: Forbion Capital Fund IV Cooperatief U.A.
Showing 1-6 of 15 holder rows.
Quick read
Forbion Capital Fund IV Cooperatief U.A. leads the comparable SEC ownership view at 4.8%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Forbion Capital Fund IV Cooperatief U.A.'s linked filing trail.
Comparable ownership
Top 5
Forbion Capital Fund IV Cooperati...
4.8%
RTW INVESTMENTS, LP
1.5%
Point72 Asset Management, L.P.
1.5%
Atlas Venture Life Science Adviso...
4.9%
FMR LLC
4.9%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Forbion Capital Fund IV Cooperatief U.A. |
13D/G
ForDyne B.V.
|
4.8%
|
$60,000,055
5,400,545 shares
|
$0 | 31 Mar 2025 |
| RTW INVESTMENTS, LP |
13F
13D/G
Company
|
1.5%
from 13D/G
|
$122,951,182
5,218,641 shares
|
— | 31 Dec 2024 |
| Point72 Asset Management, L.P. |
13F
13D/G
Company
|
1.5%
from 13D/G
|
$21,785,476
924,681 shares
|
— | 31 Dec 2024 |
| Atlas Venture Life Science Advisors, LLC |
13F
Company
|
4.9%
|
$188,935,980
8,019,354 shares
|
— | 31 Dec 2024 |
| FMR LLC |
13F
Company
|
4.9%
|
$188,407,695
7,996,931 shares
|
— | 31 Dec 2024 |
| BlackRock, Inc. |
13F
Company
|
4.8%
|
$187,287,912
7,949,402 shares
|
— | 31 Dec 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
1
Shares
18,546
Rows available
1
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2025 vs Q1 2025 Across Filers
Q1 2025 holders
1
Q1 2025 holders
1
Holder diff
0
| Investor | Q1 2025 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q1 2025 value | Q1 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend